Introduction for behavioral rhythmicity has been demonstrated in both mice and humans. A mutation of the mPer2 gene A circadian clock in the mammalian suprachiasmatic resulting in deletion of 87 residues from the protein dinuclei (SCN) regulates rhythms in physiology and behavmerization PAS domain (mPer2
Brdm1
) leads to circadian ior (for reviews, see Weaver, 1998; Klein et al., 1991).
instability and delayed arrhythmicity in mice (Zheng et SCN neurons contain a cell-autonomous circadian clock al., 1999). In humans, a mutation in Per2 that reduces (Welsh et al., 1995) . The circadian mechanism is thought the ability of hPER2 to be phosphorylated by casein to be a self-sustaining transcriptional/translational feedkinase I⑀ is associated with familial advanced sleep back loop in which the expression of putative "clock phase syndrome, an abnormality in the circadian timing genes" is suppressed periodically by their protein prodsystem affecting the timing of sleep (Toh et al., 2001). ucts (Dunlap,1999; Reppert and Weaver, 2001 ). tal stimuli. mPer1 and mPer2 mRNA levels increase in are thus referred to as "mPER1-deficient mice." targeted disruption of mPer3 combined with disruption of either mPer1 or mPer2 were similar to rhythms in mice with disruption of mPer1 or mPer2 alone, indicating Generation of Mice with Targeted Disruption of mPer2 that the lack of robust phenotype in mPER3-deficient mice is not due to functional redundancy among memAn mPer2 targeting construct was generated by replacing a portion of genomic DNA containing exon 5 and a bers of the mPer gene family and confirming the placement of mPer3 outside the core circadian clockwork.
portion of exon 6 with a neomycin resistance cassette In wild-type mice (ϩ/ϩ), a major transcript band at ‫7ف‬ kb was detected with probes directed to both the 5Ј and 3Ј cDNA sequence relative to the site of insertion of the neomycin resistance cassette (band A). In mice homozygous for the targeted allele (Ϫ/Ϫ), the major transcript identified with the 5Ј probe (B) was ‫8.0ف‬ kb: this transcript also hybridized with a probe based on sequence from intron 4 (data not shown). Minor, long transcripts were also detectable in the homozygous mutant mice with both the 5Ј and 3Ј probes, likely corresponding to transcripts in which exon 4 is directly spliced histochemistry data in Figure 2 show that this possible deletion mutant mPER2 protein is not present at detectable levels in the SCN. We conclude that this mPer2 allele represents a null allele at the level of the SCN. (Figure 1D (Figure 3 and Experimental Procedures). These exons encode the first 147 residues of to a 12 hr light, 12 hr dark lighting cycle (LD), followed by exposure to constant darkness (DD) (Figure 4 ). In LD, mPER2; the potential products of these transcripts would lack the entire PAS domain and the remainder of all mice showed higher levels of activity at night, as expected for a nocturnal species. Upon transfer to DD, the coding region. A relatively rare transcript form was also detected in which exon 4 was spliced directly to mice of all genotypes initially showed free-running circadian rhythms. The timing of activity onset in DD was exon 7. This splicing event maintains the reading frame Bmal1 RNA levels varied significantly with time, but the data from each of two independent experiments were not sinusoidal in shape, e.g., were not rhythmic per se. center panel). All 24 wild-type mice studied in parallel with the mutant animals maintained rhythmicity throughTwo-way analysis of variance revealed a significant main effect of circadian time for each of the four genes, as out the study.
The mean free-running period of locomotor activity well as a significant effect of genotype (mCry1, Bmal1) or a significant interaction (mPer1, mPer2). Post-hoc, rhythms upon initial placement in DD did not vary by other mPer gene, then the phenotype of double-mutant mice should be markedly more severe than the phenomPER2 immunoreactivity was not detected in the brain of mPer2 ldc mice (Figure 2 ). mPER1 and mCRY1 type of the mutations assessed individually. In fact, however, the circadian phenotype of double-mutant mice nuclear immunoreactivity remained rhythmic in the mutant mice (p Ͻ 0.05), but there were marked reductions was no more severe than the phenotype of the more severely affected parental line (Figure 9 ). These data in the peak level of these antigens in the SCN relative to wild-type controls (Figure 7) . support the conclusion previously drawn from study of mPER3-deficient mice, that mPER3 does not play an To determine the specificity of the alterations in nuclear mPER1 and mPER2 immunoreactivity in the SCN important role in the circadian clock mechanism regulating locomotor activity. of mice with targeted mPer gene disruptions, we compared mPer3-deficient mice with matched wild-type Mice homozygous for mutations of both mPer1 and mPer2 were also examined. Each of the four mPer1/ mice on the first day in DD. Numbers of nuclei immunoreactive for mPER1 and mPER2 assessed during the day mPer2 double-mutant mice showed an abrupt loss of rhythmicity immediately upon transfer to DD ( deficient and mPer2 ldc mutant mice were similar, the unaltered levels of the corresponding mRNAs, strongly suggest that mPER1 contributes to the ability of mPER2 molecular characteristics of mice bearing these lesions were distinct (Table 1) . While the present data focus our attention on a transcriptional role for mPER2 and a posttranscriprepressor of transcription in vivo, an increase in levels of mPer2 and mCry1 RNA levels would be expected in tional role for mPER1, it is likely that each protein contributes to the circadian feedback loop in several ways. mPER1-deficient mice. This was not observed. Therefore, mPER1 seems unlikely to act as a significant reguIn all lines of mice studied (including mice with disruption of mPer1, mPer2, as well as the mPer1/mPer3 and lator (activator or repressor) of the transcription of these genes in vivo. The reductions in the number of mPER2 mPer2/mPer3 combinations), the initial phase of activity onset in DD was consistent with the phase of activity and mCRY1 immunoreactive nuclei, occurring despite XhoI, and the ‫006ف‬ bp fragment was ligated to an upstream XhoIaccession number AB030818, the 5Ј arm in the targeting construct corresponds to nt 2106-6665, the deleted region corresponds to nt SacII fragment in the vector Bluescript KS, resulting in generation of a 4.5 kb 5Ј arm flanked by XhoI sites. The 3Ј arm of the construct 6666-9566, and the 3Ј end arm is approximately 9 kb in length, extending ‫3ف‬ kb farther 3Ј than the sequence reported in GenBank was generated by digestion of a genomic clone with ClaI, followed by insertion of the neomycin cassette on the 5Ј end of the ClaI site. accession number AB030818. The neomycin resistance cassette consists of the phosphoglycerate kinase promoter driving expression of the neomycin resistance gene mPer2 Targeting Construct A genomic clone was isolated from a 129sv mouse library (Stra-(provided by Dr. En Li, Massachusetts General Hospital, Boston). The final construct was assembled by ligation of the 4.5 kb 5Ј arm tagene) using a probe generated from the 5Ј region of the mPer2 cDNA (nt 9-489 of AF035830). A ‫01ف‬ kb SmaI-MfeI fragment was into the vector containing the neomycin resistance cassette and the 9 kb 3Ј arm. In the targeting vector, the neomycin construct replaced isolated from the genomic clone and subcloned to Bluescript. This fragment became the 5Ј arm of the targeting construct; the MfeI the genomic region extending from exon 2 (96 bp 5Ј of the presumed mPER1 translational start site) through the ClaI site in exon 12. The site on its 3Ј end is located in intron 4. The 3Ј arm, ‫3ف‬ kb, extended from an AatII site in exon 6 to the 3Ј end of the clone. The neomycin seams of the construct were sequenced to verify proper assembly of the construct. A partial sequence of the mouse mPer1 gene has resistance cassette was inserted in reverse orientation, replacing ‫4.1ف‬ kb of genomic DNA, including exon 5 and a portion of exon been reported (Hida et al., 2000) . Using the numbering in GenBank 6 (corresponding to amino acid residues A148-V234 of GenBank PCR genotyping for mPer2 utilized a cocktail of three primers (see Figure 1F) . A forward primer in intron 5 (xj11; 5Ј-AGA number AF035830).
ACTTGTTGCTCCTGCTT-3Ј) and a reverse primer in exon 6 (xj8; 5Ј-GGAAGCTTGTAAGGGGTGGT-3Ј, corresponding to the reverse Generation of Mice with Targeted and 4 (5Ј-GGAGTGTGAAGCAGGTGAAGG-3Ј). The reverse primer Southern blots of digested ES cell DNA were screened by hybridwas located in exon 10 (5Ј-GAGTCTTCTCCTCTGGGCACGGGG-3Ј). ization with a 3Ј probe from the mPer2 genomic region flanking the RT-PCR with these primer pairs revealed that exon 4 was spliced targeting construct. One candidate ES cell line (#424) was selected directly to exon 7 in the mice with the targeted disruption (see and confirmed using a 5Ј flanking probe. This ES line was used for below). No other products were detected with these primer pairs. microinjection, generated chimeric founders with germline transmisIn wild-type mice, the products were consistent with the published sion of the targeted allele. cDNA sequence. Chimeric males were bred to isogenic (129/sv) females generously 3Ј-RACE was performed using the Marathon cDNA Amplification provided by Dr. En Li. F1's receiving the targeted allele were inKit (Clontech). cDNA was prepared from whole brain of wild-type terbred to produce F2 mice homozygous for the targeted allele and mPer2 ldc mice collected at CT 10. Two gene-specific forward or homozygous for the wild-type allele. Mice homozygous for the primers were used: 5Ј-AGCACAACCCCTCCACGAGCGG-3Ј (exon 3) targeted mPer1 or mPer2 alleles were viable and fertile, with no and 5Ј-GCCCTGCGGAGTGTGAAGCAGGTGAAGG-3Ј (exon 4). gross abnormalities. All studies were conducted using mice of isoProducts were eluted from agarose gels (Qiaex II kit, Qiagen), subgenic (129/sv) background.
cloned into pCRII vector using a TOPO Cloning kit (Invitrogen), and the inserts were sequenced. Primer pairs based on the sequence Genotype Determination of RACE products were used in RT-PCR to verify the existence of Genotypes were determined by PCR and/or Southern blot analysis transcripts identified by RACE. of tail biopsy DNA (Figure 1) . DNA was digested with EcoRI for Northern blot analysis was performed as previously described Southern blot analysis. Probes for Southern blots were the 5Ј and Finally, RACE and RT-PCR detected a transcript form contained PCR-generated fragments of cDNAs subcloned into TA vector (Invitrogen). Probes were as follows: mPer1 (nt 340-761 of accession exon 4 spliced directly to exon 7; in this transcript, the reading frame was maintained as in native mPER2. This transcript could, if number AF022992), mPer2 (nt 9-489 of accession number AF035830), mCry1 (nt 1081-1793 of accession number AB000777), translated, result in a deletion mutant mPER2 protein lacking 108 amino acids encoded by exons 5 and 6 (148-255). Northern blot and Bmal1 (nt 864-1362 of AF015203). Adjacent sections from the same groups of mice were used for all probes in each study. analysis with a probe directed to the 3Ј region of the mPer2 cDNA revealed that large transcripts were indeed present in mice homozyStatistical analysis of RNA rhythms was conducted using Statview. Two-way analysis of variance (ANOVA) was used to identify gous for the targeted mPer2 allele. These larger transcript forms represent a small proportion of the total transcripts containing the differences between the genotypes, across time, and interaction between these variables. One-way ANOVA was used to verify signifi-5Ј region (Figure 3 
